Page last updated: 2024-09-04

birb 796 and mart-1 antigen

birb 796 has been researched along with mart-1 antigen in 1 studies

Compound Research Comparison

Studies
(birb 796)
Trials
(birb 796)
Recent Studies (post-2010)
(birb 796)
Studies
(mart-1 antigen)
Trials
(mart-1 antigen)
Recent Studies (post-2010) (mart-1 antigen)
1375801,24199446

Protein Interaction Comparison

ProteinTaxonomybirb 796 (IC50)mart-1 antigen (IC50)
HLA class I histocompatibility antigen, A alpha chain Homo sapiens (human)0.2624
5-hydroxytryptamine receptor 2CRattus norvegicus (Norway rat)0.2624
5-hydroxytryptamine receptor 2ARattus norvegicus (Norway rat)0.2624
5-hydroxytryptamine receptor 2BRattus norvegicus (Norway rat)0.2624
Gastrin/cholecystokinin type B receptorHomo sapiens (human)0.2624

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, S; Du, L; Han, X; Hu, C; Jin, A; Li, L; Li, S; Pang, D; Shen, M; Tao, K; Wang, W; Zhang, J1

Other Studies

1 other study(ies) available for birb 796 and mart-1 antigen

ArticleYear
p38 inhibition enhances TCR-T cell function and antagonizes the immunosuppressive activity of TGF-β.
    International immunopharmacology, 2021, Volume: 98

    Topics: Cell Line; Genetic Engineering; Granzymes; Humans; Immune Tolerance; Immunotherapy, Adoptive; Interferon-gamma; Lymphocyte Activation; MART-1 Antigen; Naphthalenes; p38 Mitogen-Activated Protein Kinases; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrazoles; Receptors, Antigen, T-Cell; T-Lymphocytes; Transforming Growth Factor beta

2021